Table 2 Prescribed medications in patients with delirium.
From: Factors affecting hallucinations in patients with delirium
Type of medication | Total (%) | Perceptual disturbance and hallucinations (DRS-R-98): 0–3 | |||
|---|---|---|---|---|---|
Not present (%) | Mild perceptual disturbance (%) | Illusions present (%) | Hallucinations present (%) | ||
Corticosteroids | 12 | 15 | 10 | 7 | 13 |
Opioid analgesics | 22 | 21 | 25 | 26 | 19 |
Anticholinergicsa | 25 | 20 | 28 | 22 | 26 |
Histamine 1 (H1) receptor blockers | 7 | 11 | 6 | 4 | 6 |
Histamine 2 (H2) receptor blockers | 12 | 15 | 11 | 11 | 11 |
Calcium (Ca) channel blockers | 36 | 37 | 36 | 26 | 38 |
β-blockers | 21 | 20 | 23 | 22 | 17 |
Angiotensin-converting enzyme inhibitors | 6 | 3 | 12 | 0 | 2 |
Angiotensin II receptor blockers | 14 | 11 | 13 | 19 | 19 |
Antiarrhythmic drugsb | 4 | 5 | 3 | 4 | 5 |
Digitalis | 1 | 2 | 1 | 0 | 2 |
Dopamine receptor agonists | 2 | 2 | 1 | 0 | 7 |
Nonsteroidal anti-inflammatory drugs | 29 | 35 | 24 | 26 | 28 |
Antibiotics | 48 | 47 | 51 | 56 | 43 |
Anticonvulsants | 4 | 2 | 5 | 4 | 6 |
Cholinesterase inhibitors | 6 | 5 | 8 | 7 | 4 |
Benzodiazepines | 58 | 56 | 61 | 63 | 54 |
Suvorexant | 18 | 15 | 19 | 7 | 21 |
Ramelteon | 11 | 7 | 12 | 11 | 12 |